Skip to main content
CDC Website

INH: Standing Between You and Tuberculosis

This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.

Audiences:
Non-U.S.-born persons
Persons With LTBI
Author:
Florida Department of Health, Florida Department of Health, Bureau of TB and Refugee Health
Focus Area:
TB
Subjects:
Treatment- Adverse Reactions
Treatment - Latent TB infection (Inactive TB)
Treatment- Medication Information
Treatment- Patient Adherence
Publication Date:
2004
Format:
Brochure